Rajesh Chand Arya
Rajesh Chand Arya has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Bishav Mohan
Department of Cardiology, Hero DMC Heart Institute, Ludhiana, Punjab, India
2 shared publicationsGurpreet S Wander
Department of Cardiology, Hero DMC Heart Institute, Ludhiana, Punjab, India
2 shared publicationsSarju Ralhan
Department of CTVS, Chief Cardiac Surgeon, Hero DMC Heart Institute, Ludhiana, Punjab, India
2 shared publicationsAbhishek Goyal
Department of Anaesthesia, DMCH, Ludhiana, Punjab, India
1 shared publicationBhupinder Singh
Department of Cardiology, DMCH, Ludhiana, Punjab, India
1 shared publicationGs Wander
Department of Cardiology, Hero DMC Heart Institute, Ludhiana
1 shared publication
Latest Publications
- Open Access
- 31 July 2025
- Published by Biomedical Informatics in Bioinformation
- Vol. 21 (07) , 2133-2139
Clinical and echocardiographic outcomes of combined CABG and MV repair
A mixed-method observational study evaluated patients undergoing Coronary Artery Bypass Grafting (CABG) with mitral valve (MV) repair for moderate to severe mitral regurgitation (MR). Most patients aged between 61–70 years (46.3%) and with 60% being male, 73% with Type 2 diabetes and 83.33% with triple-vessel coronary artery disease (CAD) (83.8%) and 15% with left main CAD. At discharge, 94.7% improved to NYHA class II and residual MR was eliminated in 97.1% patients. This study demonstrates significantly improved 12-month outcomes, with elimination of residual MR, supporting CABG with concomitant MV repair as a viable option for IMR patients despite high comorbidity.
- 31 July 2025
- Published by Biomedical Informatics in Bioinformation
- Vol. 21 (07) , 2133-2139
Open AccessClinical and echocardiographic outcomes of combined CABG and MV repair
A mixed-method observational study evaluated patients undergoing Coronary Artery Bypass Grafting (CABG) with mitral valve (MV) repair for moderate to severe mitral regurgitation (MR). Most patients aged between 61–70 years (46.3%) and with 60% being male, 73% with Type 2 diabetes and 83.33% with triple-vessel coronary artery disease (CAD) (83.8%) and 15% with left main CAD. At discharge, 94.7% improved to NYHA class II and residual MR was eliminated in 97.1% patients. This study demonstrates significantly improved 12-month outcomes, with elimination of residual MR, supporting CABG with concomitant MV repair as a viable option for IMR patients despite high comorbidity.
- Open Access
- 1 January 2020
- Published by Medknow in Annals of Cardiac Anaesthesia
- Vol. 23 (4) , 485-492
Cardiothoracic surgery during COVID-19: Our experience with different strategies
Background: An acute respiratory disease (COVID-19), caused by a novel coronavirus (SARS-CoV-2,), has been declared a pandemic by WHO. A surgery on COVID-19 patients not only involves a risk of spread of the disease but also there is a serious concern for the patient's surgical outcomes and resources requirement. Aim: The retrospective study is aimed to provide a protocol for pre-operative testing of SARS CoV-2 using RT-PCR in the patient undergoing cardio-thoracic surgeries. Material and Methods: To analyze the impact of pre-operative testing of SARS- CoV-2 using RT-PCR in the patient undergoing elective cardio-thoracic surgeries. The patient who underwent surgical interventions during the COVID-19 lockdown period was divided into two phases. Phase I (without COVID-19 RT-PCR testing) and Phase II (with pre-operative COVID-19 RT-PCR testing). The retrospective comparison between the two study groups was done using Student t-test, Mann–Whitney U, and Chi square (χ2) test depending upon the clinical variable to be analyzed. Results: During the early phase (phase I), 26 patients underwent cardio-thoracic surgery without COVID-19 RT-PCR test. Whereas, during phase II, all patients were tested for COVID-19 using RT-PCR, preoperatively and a total of 64 surgeries were performed during this phase. One patient planned for CABG was positive on RT-PCR for COVID-19 and was sent to the quarantine ward. The difference in the pre-operative hospital stay between two groups was found to be statistically significant and a significant decrease in the number of PPE kits used, during the phase I. Conclusion: All asymptomatic patients should be tested for COVID-19 using RT-PCR prior to cardio-thoracic surgeries not only to contain the disease but to avoid potential implications of COVID-19 on the perioperative course, without added financial implications.
- 1 January 2020
- Published by Medknow in Annals of Cardiac Anaesthesia
- Vol. 23 (4) , 485-492
Open AccessCardiothoracic surgery during COVID-19: Our experience with different strategies
Background: An acute respiratory disease (COVID-19), caused by a novel coronavirus (SARS-CoV-2,), has been declared a pandemic by WHO. A surgery on COVID-19 patients not only involves a risk of spread of the disease but also there is a serious concern for the patient's surgical outcomes and resources requirement. Aim: The retrospective study is aimed to provide a protocol for pre-operative testing of SARS CoV-2 using RT-PCR in the patient undergoing cardio-thoracic surgeries. Material and Methods: To analyze the impact of pre-operative testing of SARS- CoV-2 using RT-PCR in the patient undergoing elective cardio-thoracic surgeries. The patient who underwent surgical interventions during the COVID-19 lockdown period was divided into two phases. Phase I (without COVID-19 RT-PCR testing) and Phase II (with pre-operative COVID-19 RT-PCR testing). The retrospective comparison between the two study groups was done using Student t-test, Mann–Whitney U, and Chi square (χ2) test depending upon the clinical variable to be analyzed. Results: During the early phase (phase I), 26 patients underwent cardio-thoracic surgery without COVID-19 RT-PCR test. Whereas, during phase II, all patients were tested for COVID-19 using RT-PCR, preoperatively and a total of 64 surgeries were performed during this phase. One patient planned for CABG was positive on RT-PCR for COVID-19 and was sent to the quarantine ward. The difference in the pre-operative hospital stay between two groups was found to be statistically significant and a significant decrease in the number of PPE kits used, during the phase I. Conclusion: All asymptomatic patients should be tested for COVID-19 using RT-PCR prior to cardio-thoracic surgeries not only to contain the disease but to avoid potential implications of COVID-19 on the perioperative course, without added financial implications.
- Open Access
HealthFog: An Ensemble Deep Learning based Smart Healthcare System for Automatic Diagnosis of Heart Diseases in Integrated IoT and Fog Computing Environments
Cloud computing provides resources over the Internet and allows a plethora of applications to be deployed to provide services for different industries. The major bottleneck being faced currently in these cloud frameworks is their limited scalability and hence inability to cater to the requirements of centralized Internet of Things (IoT) based compute environments. The main reason for this is that latency-sensitive applications like health monitoring and surveillance systems now require computation over large amounts of data (Big Data) transferred to centralized database and from database to cloud data centers which leads to drop in performance of such systems. The new paradigms of fog and edge computing provide innovative solutions by bringing resources closer to the user and provide low latency and energy-efficient solutions for data processing compared to cloud domains. Still, the current fog models have many limitations and focus from a limited perspective on either accuracy of results or reduced response time but not both. We proposed a novel framework called HealthFog for integrating ensemble deep learning in Edge computing devices and deployed it for a real-life application of automatic Heart Disease analysis. HealthFog delivers healthcare as a fog service using IoT devices and efficiently manages the data of heart patients, which comes as user requests. Fog-enabled cloud framework, FogBus is used to deploy and test the performance of the proposed model in terms of power consumption, network bandwidth, latency, jitter, accuracy and execution time. HealthFog is configurable to various operation modes that provide the best Quality of Service or prediction accuracy, as required, in diverse fog computation scenarios and for different user requirements.
Open AccessHealthFog: An Ensemble Deep Learning based Smart Healthcare System for Automatic Diagnosis of Heart Diseases in Integrated IoT and Fog Computing Environments
Cloud computing provides resources over the Internet and allows a plethora of applications to be deployed to provide services for different industries. The major bottleneck being faced currently in these cloud frameworks is their limited scalability and hence inability to cater to the requirements of centralized Internet of Things (IoT) based compute environments. The main reason for this is that latency-sensitive applications like health monitoring and surveillance systems now require computation over large amounts of data (Big Data) transferred to centralized database and from database to cloud data centers which leads to drop in performance of such systems. The new paradigms of fog and edge computing provide innovative solutions by bringing resources closer to the user and provide low latency and energy-efficient solutions for data processing compared to cloud domains. Still, the current fog models have many limitations and focus from a limited perspective on either accuracy of results or reduced response time but not both. We proposed a novel framework called HealthFog for integrating ensemble deep learning in Edge computing devices and deployed it for a real-life application of automatic Heart Disease analysis. HealthFog delivers healthcare as a fog service using IoT devices and efficiently manages the data of heart patients, which comes as user requests. Fog-enabled cloud framework, FogBus is used to deploy and test the performance of the proposed model in terms of power consumption, network bandwidth, latency, jitter, accuracy and execution time. HealthFog is configurable to various operation modes that provide the best Quality of Service or prediction accuracy, as required, in diverse fog computation scenarios and for different user requirements.
- Open Access
- 1 January 2019
- Published by Medknow in Annals of Cardiac Anaesthesia
- Vol. 22 (2) , 229-232
Unusual case of intraoperative acute cor pulmonale during spine surgery
Perioperative complications of prolonged surgery and prone positioning are well known. Changing the position from prone to supine in an anesthetized patient can result in aspiration and airway obstruction. The drop-in oxygen saturation and hemodynamic changes are warning signs and can cause acute cardiac decompensation leading to diagnostic dilemma. We present a case where the patient had these changes after changing the position after spine surgery in prone position. A quick response from the treating anesthesiologist and active involvement of cardiologist helped in reaching the diagnosis and successful management of aspiration pneumonitis in this patient. We conclude that a quick response in investigations and multimodality approach helps in the management of such perioperative complications.
- 1 January 2019
- Published by Medknow in Annals of Cardiac Anaesthesia
- Vol. 22 (2) , 229-232
Open AccessUnusual case of intraoperative acute cor pulmonale during spine surgery
Perioperative complications of prolonged surgery and prone positioning are well known. Changing the position from prone to supine in an anesthetized patient can result in aspiration and airway obstruction. The drop-in oxygen saturation and hemodynamic changes are warning signs and can cause acute cardiac decompensation leading to diagnostic dilemma. We present a case where the patient had these changes after changing the position after spine surgery in prone position. A quick response from the treating anesthesiologist and active involvement of cardiologist helped in reaching the diagnosis and successful management of aspiration pneumonitis in this patient. We conclude that a quick response in investigations and multimodality approach helps in the management of such perioperative complications.
- 1 April 2013
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 27 (2) , 321-322
Removal of a Foreign Body From the Heart Under Transesophageal Echocardiographic Guidance
- 1 April 2013
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 27 (2) , 321-322
Removal of a Foreign Body From the Heart Under Transesophageal Echocardiographic Guidance
- Open Access
- 1 January 2012
- Published by Medknow in Annals of Cardiac Anaesthesia
- Vol. 15 (3) , 229-32
TEE-guided left ventricular epicardial pacing lead placement for cardiac resynchronization therapy
Biventricular pacing has demonstrated improvement in cardiac functions in treating congestive cardiac failure patients. Recent trials have proven the clinical and functional benefits of cardiac resynchronization therapy in severe heart failure and intraventricular cardiac delays, mainly left bundle branch block. Biventricular pacing improves the exercise tolerance, quality of life, systolic heart function, reduces hospitalization and slows progression of the disease. A 54-year-old lady, a known case of dilated cardiomyopathy, was on biventricular pacing since 2 years. She presented in emergency with sudden deterioration of dyspnea to NYHA class III/IV. When investigated, the coronary sinus lead was found displaced; thus, left ventricle (LV) was not getting paced. After multiple failures to reposition the coronary sinus lead, it was decided to surgically place the epicardial lead for LV pacing under general anesthesia. Lateral thoracotomy was done and LV pacing lead was placed at different sites with simultaneous monitoring of cardiac output (CO) and stroke volume (SV) by transesophageal echocardiography (TEE). Baseline CO and SV were 1.9 l/min and 19.48 ml respectively and increased at different sites of pacing at LV, the best CO and SV were 4.2 l/min and 42.39 ml respectively on lateral surface. Intraoperative TEE can calculate beat to beat stroke volume and thus CO and helps to choose optimal site for placement of epicardial pacing lead.
- 1 January 2012
- Published by Medknow in Annals of Cardiac Anaesthesia
- Vol. 15 (3) , 229-32
Open AccessTEE-guided left ventricular epicardial pacing lead placement for cardiac resynchronization therapy
Biventricular pacing has demonstrated improvement in cardiac functions in treating congestive cardiac failure patients. Recent trials have proven the clinical and functional benefits of cardiac resynchronization therapy in severe heart failure and intraventricular cardiac delays, mainly left bundle branch block. Biventricular pacing improves the exercise tolerance, quality of life, systolic heart function, reduces hospitalization and slows progression of the disease. A 54-year-old lady, a known case of dilated cardiomyopathy, was on biventricular pacing since 2 years. She presented in emergency with sudden deterioration of dyspnea to NYHA class III/IV. When investigated, the coronary sinus lead was found displaced; thus, left ventricle (LV) was not getting paced. After multiple failures to reposition the coronary sinus lead, it was decided to surgically place the epicardial lead for LV pacing under general anesthesia. Lateral thoracotomy was done and LV pacing lead was placed at different sites with simultaneous monitoring of cardiac output (CO) and stroke volume (SV) by transesophageal echocardiography (TEE). Baseline CO and SV were 1.9 l/min and 19.48 ml respectively and increased at different sites of pacing at LV, the best CO and SV were 4.2 l/min and 42.39 ml respectively on lateral surface. Intraoperative TEE can calculate beat to beat stroke volume and thus CO and helps to choose optimal site for placement of epicardial pacing lead.
- Open Access
- 1 January 2011
- Published by Medknow in Journal of Anaesthesiology Clinical Pharmacology
- Vol. 27 (2) , 278-84
Blood component therapy: Which, when and how much
Blood transfusion refers to the perioperative administration of blood and blood components. Adherence to proper indications for blood component therapy is essential because of its potential adverse effects and costs of transfusion. Over the years, the significance of blood components in treating certain diseases or conditions has been recognized. In this article, the most commonly used blood components along with the new developments in component therapy have been discussed. Recommendations by different academic and clinical trials and studies have been presented for quick reference. The individual coagulation factors are discussed in brief.
- 1 January 2011
- Published by Medknow in Journal of Anaesthesiology Clinical Pharmacology
- Vol. 27 (2) , 278-84
Open AccessBlood component therapy: Which, when and how much
Blood transfusion refers to the perioperative administration of blood and blood components. Adherence to proper indications for blood component therapy is essential because of its potential adverse effects and costs of transfusion. Over the years, the significance of blood components in treating certain diseases or conditions has been recognized. In this article, the most commonly used blood components along with the new developments in component therapy have been discussed. Recommendations by different academic and clinical trials and studies have been presented for quick reference. The individual coagulation factors are discussed in brief.